These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8614531)

  • 1. Side effect profile of interferon beta-1b in MS: results of an open label trial.
    Neilley LK; Goodin DS; Goodkin DE; Hauser SL
    Neurology; 1996 Feb; 46(2):552-4. PubMed ID: 8614531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type.
    Nikfar S; Rahimi R; Abdollahi M
    Clin Ther; 2010 Oct; 32(11):1871-88. PubMed ID: 21095482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose steroids reduce flu-like symptoms at the initiation of IFNbeta-1b in relapsing-remitting MS.
    Río J; Nos C; Marzo ME; Tintoré M; Montalban X
    Neurology; 1998 Jun; 50(6):1910-2. PubMed ID: 9633761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing side effects of interferon-beta in patients with relapsing-remitting multiple sclerosis.
    Munschauer FE; Kinkel RP
    Clin Ther; 1997; 19(5):883-93. PubMed ID: 9385477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of patients receiving interferon beta-1b for multiple sclerosis: report of a consensus conference.
    Lublin FD; Whitaker JN; Eidelman BH; Miller AE; Arnason BG; Burks JS
    Neurology; 1996 Jan; 46(1):12-8. PubMed ID: 8559358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quality-of-life effects of interferon beta-1b in multiple sclerosis. An extended Q-TWiST analysis.
    Schwartz CE; Coulthard-Morris L; Cole B; Vollmer T
    Arch Neurol; 1997 Dec; 54(12):1475-80. PubMed ID: 9400356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emotional state of patients with relapsing-remitting MS treated with interferon beta-1b.
    Borràs C; Río J; Porcel J; Barrios M; Tintoré M; Montalban X
    Neurology; 1999 May; 52(8):1636-9. PubMed ID: 10331691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon beta-1b.
    Goodkin DE
    Lancet; 1994 Oct; 344(8929):1057-60. PubMed ID: 7934448
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary myelin basic protein-like material in patients with multiple sclerosis during interferon beta-1b treatment.
    Whitaker JN; Layton BA; Bartolucci AA; Mitchell GW; Bashir K; Goodwin J; Kachelhofer RD
    Arch Neurol; 1999 Jun; 56(6):687-91. PubMed ID: 10369307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-beta-1b: a review of its use in relapsing-remitting and secondary progressive multiple sclerosis.
    McCormack PL; Scott LJ
    CNS Drugs; 2004; 18(8):521-46. PubMed ID: 15182221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Side effect profile and adherence to in the treatment of multiple sclerosis with interferon beta-1a.
    Mohr DC; Likosky W; Boudewyn AC; Marietta P; Dwyer P; Van der Wende J; Goodkin DE
    Mult Scler; 1998 Dec; 4(6):487-9. PubMed ID: 9987757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon beta-1b for the treatment of multiple sclerosis.
    Petri T; Weber-Diehl F
    J Biotechnol; 1995 Nov; 43(1):74-5. PubMed ID: 8573325
    [No Abstract]   [Full Text] [Related]  

  • 13. Newer versus older treatments for relapsing-remitting multiple sclerosis.
    Weinstock-Guttman B; Cohen JA
    Drug Saf; 1996 Feb; 14(2):121-30. PubMed ID: 8852526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon beta-1B--hope or hype?
    Drug Ther Bull; 1996 Feb; 34(2):9-11. PubMed ID: 8819985
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon beta treatment for multiple sclerosis: persisting questions.
    Goodkin DE
    Mult Scler; 1996 Jul; 1(6):321-4. PubMed ID: 9345408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune hyperthyroidism in patients with multiple sclerosis treated with interferon beta-1b.
    Schwid SR; Goodman AD; Mattson DH
    Arch Neurol; 1997 Sep; 54(9):1169-90. PubMed ID: 9311363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spotlight on Interferon-beta-1b in relapsing-remitting and secondary progressive multiple sclerosis.
    McCormack PL; Scott LJ
    BioDrugs; 2004; 18(5):343-7. PubMed ID: 15377176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS.
    Lancet; 1998 Nov; 352(9139):1491-7. PubMed ID: 9820296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon beta for multiple sclerosis.
    Connelly JF
    Ann Pharmacother; 1994 May; 28(5):610-6. PubMed ID: 8069001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis.
    Mohr DC; Goodkin DE; Likosky W; Gatto N; Baumann KA; Rudick RA
    Arch Neurol; 1997 May; 54(5):531-3. PubMed ID: 9152109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.